Patents Assigned to Medvill Co., Ltd.
  • Publication number: 20080085333
    Abstract: The present invention relates to a composition comprising a water or organic solvent extract of Anemarrhena asphodeloides and Aralia elata, and the use thereof. The composition has a preventive or therapeutic effect on inflammatory skin diseases and an antibacterial effect against Propionibacterium acnes.
    Type: Application
    Filed: October 18, 2005
    Publication date: April 10, 2008
    Applicant: MEDVILL CO., LTD.
    Inventors: Eun-Kyung Hong, Young-Shin Chung
  • Patent number: 6827950
    Abstract: The present invention relates to Aralia extracts and a therapeutic agent comprising Aralia extracts as an active ingredient. The composition and therapeutic agent according to the present invention are effective in preventing cataract, delaying the development of cataract, and treating cataract. According to the present invention, extracts of Aralia are obtained by extraction with alcohol. Addition of myo-inositol or taurine to the extracts will result in a synergistic effect in the treatment of cataract. In addition, oral administration of beverages, galenicals, and nutraceuticals, which comprise Aralia extracts as an active ingredient, will be effective in prevention, delay and treatment of cataract caused by complications of diabetes. Aralia extracts will have the same effect in the case where they are used as an ophthalmic agent. They can also be used as an eye drop or an eye ointment.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: December 7, 2004
    Assignee: Medvill Co., Ltd.
    Inventors: Eun-Kyung Hong, Young-Shin Chung, Yeong-Bok Han, Yun Hui Choi, Seong-Jin Kim, Hae-Ri Kim, Bu-Hyeon Kang
  • Publication number: 20040033274
    Abstract: The present invention relates to Aralia extracts and a therapeutic agent comprising Aralia extracts as an active ingredient. The composition and therapeutic agent according to the present invention are effective in preventing cataract, delaying the development of cataract, and treating cataract. According to the present invention, extracts of Aralia are obtained by extraction with alcohol. Addition of myo-inositol or taurine to the extracts will result in a synergistic effect in the treatment of cataract. In addition, oral administration of beverages, galenicals, and nutraceuticals, which comprise Aralia extracts as an active ingredient, will be effective in prevention, delay and treatment of cataract caused by complications of diabetes. Aralia extracts will have the same effect in the case where they are used as an ophthalmic agent. They can also be used as an eye drop or an eye ointment.
    Type: Application
    Filed: August 15, 2002
    Publication date: February 19, 2004
    Applicant: Medvill Co., Ltd.
    Inventors: Eun-Kyung Hong, Young-Shin Chung
  • Patent number: 6589572
    Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: July 8, 2003
    Assignee: Medvill Co., Ltd.
    Inventors: Eun Kyung Hong, Young Shin Chung
  • Publication number: 20030003165
    Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.
    Type: Application
    Filed: June 14, 2001
    Publication date: January 2, 2003
    Applicant: MEDVILL CO., LTD.
    Inventors: Eun Kyung Hong, Young Shin Chung
  • Patent number: 6193977
    Abstract: The present invention is directed to a pharmaceutical composition comprising an extract of a mixture of Anemarrhena Rhizoma, a member of the family Liliaceae and, Phellodendron bark, a member of the family Rutaceae that produces analgesic and anti-inflammatory effects, and its preparing method. The present invention is applicable to act on inflammation and pain, for example, chronic gastritis, arthralgia, benign prostate hyperplasia, chronic and recurrent cystitis, cervical disc, degenerative joint arthritis, rheumatoid arthritis, tennis elbow, osteoportotic pain, migraine, diabetic neuropathy pain, right flank pain, etc. The present invention a crude extract suitable for long-period administration with less side effects. Also, the present invention does not lead to dependency or resistance.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: February 27, 2001
    Assignee: Medvill Co., Ltd.
    Inventors: Young-Bok Han, Eun-Kyung Hong, Young-Shin Chung, Sung-Jin Kim, Kyung-Yung Lee, Young-Lok Shin